These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Individual specific bias usage of HLA-DR antigens in the restriction of myelin basic protein-reactive T cell clones. Rohowsky-Kochan C; Eiman D; Cook SD J Neurol Sci; 1993 Jul; 117(1-2):120-9. PubMed ID: 7691992 [TBL] [Abstract][Full Text] [Related]
3. Regulation of myelin basic protein-specific helper T cells in multiple sclerosis: generation of suppressor T cell lines. Zhang JW; Schreurs M; Medaer R; Raus JC Cell Immunol; 1992 Jan; 139(1):118-30. PubMed ID: 1370254 [TBL] [Abstract][Full Text] [Related]
4. Human myelin basic protein-specific cytolytic T lymphocyte clones are functionally restricted by HLA class II gene products. Weber WE; Vandermeeren MM; Raus JC; Buurman WA Cell Immunol; 1989 Apr; 120(1):145-53. PubMed ID: 2467752 [TBL] [Abstract][Full Text] [Related]
5. T lymphocyte lines and clones selected against synthetic myelin basic protein 82-102 peptide from Japanese multiple sclerosis patients. Inobe J; Yamamura T; Kunishita T; Tabira T J Neuroimmunol; 1993 Jul; 46(1-2):83-90. PubMed ID: 7689597 [TBL] [Abstract][Full Text] [Related]
6. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. Zang YC; Li S; Rivera VM; Hong J; Robinson RR; Breitbach WT; Killian J; Zhang JZ J Immunol; 2004 Apr; 172(8):5120-7. PubMed ID: 15067096 [TBL] [Abstract][Full Text] [Related]
7. Human CD8+ T cell clone regulates autologous CD4+ myelin basic protein specific T cells. Chou YK; Henderikx P; Jones RE; Kotzin B; Hashim GA; Offner H; Vandenbark AA Autoimmunity; 1992; 14(2):111-9. PubMed ID: 1284651 [TBL] [Abstract][Full Text] [Related]
8. Preferential peptide specificity and HLA restriction of myelin basic protein-specific T cell clones derived from MS patients. Zhang JW; Chou CH; Hashim G; Medaer R; Raus JC Cell Immunol; 1990 Aug; 129(1):189-98. PubMed ID: 1694729 [TBL] [Abstract][Full Text] [Related]
9. Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition. Zamvil SS; Nelson PA; Mitchell DJ; Knobler RL; Fritz RB; Steinman L J Exp Med; 1985 Dec; 162(6):2107-24. PubMed ID: 2415664 [TBL] [Abstract][Full Text] [Related]
10. Cytokine mRNA profile of myelin basic protein reactive T-cell clones in patients with multiple sclerosis. Vandevyver C; Motmans K; Stinissen P; Zhang J; Raus J Autoimmunity; 1998; 28(2):77-89. PubMed ID: 9771978 [TBL] [Abstract][Full Text] [Related]
11. Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking. Aharoni R; Teitelbaum D; Arnon R; Sela M Proc Natl Acad Sci U S A; 1999 Jan; 96(2):634-9. PubMed ID: 9892685 [TBL] [Abstract][Full Text] [Related]
12. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Zhang J; Medaer R; Stinissen P; Hafler D; Raus J Science; 1993 Sep; 261(5127):1451-4. PubMed ID: 7690157 [TBL] [Abstract][Full Text] [Related]
14. Presentation of autoantigen by human T cells. LaSalle JM; Ota K; Hafler DA J Immunol; 1991 Aug; 147(3):774-80. PubMed ID: 1713605 [TBL] [Abstract][Full Text] [Related]
16. Reactivity of normal T-cell lines to MBP isolated from normal and multiple sclerosis white matter. McLaurin JA; Hafler DA; Antel JP J Neurol Sci; 1995 Feb; 128(2):205-11. PubMed ID: 7537795 [TBL] [Abstract][Full Text] [Related]
17. A review of T-cell receptors in multiple sclerosis: clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide. Wucherpfennig KW; Hafler DA Ann N Y Acad Sci; 1995 Jul; 756():241-58. PubMed ID: 7544075 [TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis. Schmidt S; Linington C; Zipp F; Sotgiu S; de Waal Malefyt R; Wekerle H; Hohlfeld R Brain; 1997 Aug; 120 ( Pt 8)():1437-45. PubMed ID: 9278633 [TBL] [Abstract][Full Text] [Related]
19. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182 [TBL] [Abstract][Full Text] [Related]
20. T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study. Van der Aa A; Hellings N; Medaer R; Gelin G; Palmers Y; Raus J; Stinissen P Clin Exp Immunol; 2003 Jan; 131(1):155-68. PubMed ID: 12519400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]